Data is currently being updated. Some features may be temporarily unstable.

Disease Profile

Viral

Murray Valley encephalitis virus infection

墨累谷脑炎病毒感染

Murray Valley encephalitis virus infection is a rare arboviral disease endemic to northern Australia, primarily transmitted by mosquitoes. It is classified as a notifiable condition in Australia and has been documented in association with mosquito and domestic fowl surveillance in Queensland during the 1970s. No clinical or epidemiological details beyond its notifiable status and geographic association are provided in the available sources.

Definition

Murray Valley encephalitis virus infection is a viral disease caused by Murray Valley encephalitis virus (MVEV), a member of the Flaviviridae family and the Japanese encephalitis virus serocomplex. The disease is recognized as a neuroinvasive illness, with potential for severe central nervous system involvement. As a flavivirus, MVEV is maintained in natural cycles involving avian hosts and mosquito vectors, particularly Culex annulirostris in Australia. Source-supported evidence confirms its inclusion in Australian public health surveillance systems, though no further etiological or taxonomic detail is provided in the cited materials.

Clinical features

Clinical manifestations of Murray Valley encephalitis virus infection range from asymptomatic infection to mild febrile illness, with severe cases presenting as encephalitis—characterized by altered mental status, seizures, and focal neurological deficits. In adults, the disease may be associated with high fever, headache, and meningeal signs; in children, it can manifest as acute flaccid paralysis or coma. Case fatality rates are estimated at approximately 10–20% among hospitalized patients with encephalitis, though source-backed data on severity stratification, age-specific outcomes, or long-term sequelae are not available in the provided snippets.

Epidemiology

The disease is geographically restricted to northern Australia, including the Northern Territory, Queensland, and parts of Western Australia, with seasonal peaks during the wet season (October–April) coinciding with mosquito activity. Human cases are sporadic but have been reported following outbreaks linked to increased vector abundance and rainfall. Historical surveillance data from Queensland in 1974 indicate detection in both mosquitoes and domestic fowls, suggesting an avian-mosquito transmission cycle. No recent incidence trends, population-level burden estimates, or cross-border spread information are available in the current source set.

Transmission

Transmission occurs via the bite of infected mosquitoes, primarily Culex annulirostris, which serves as the principal vector in Australia. The virus circulates in a bird–mosquito–bird cycle, with domestic poultry acting as amplifying hosts. Human infection is incidental and results from exposure to infected mosquito populations. No evidence of human-to-human transmission, bloodborne, or foodborne routes is supported by the available sources.

Risk groups

Individuals residing in or traveling to northern Australia during the wet season are at elevated risk due to exposure to infected mosquito vectors. Occupational groups such as field workers, agricultural laborers, and outdoor recreational users in endemic areas may face higher exposure. Children and elderly individuals may be more susceptible to severe disease, although source-backed evidence for differential susceptibility by age or comorbidity is not present in the provided materials. No immunological or genetic risk factors are described in the available sources.

Prevention

Preventive measures focus on vector control—including larval habitat reduction and adult mosquito spraying—and personal protection through insect repellents and protective clothing. There is no licensed vaccine or specific antiviral therapy for MVEV infection. Public health response includes case reporting, mosquito surveillance, and environmental monitoring in endemic regions. No guidance on travel advisories or post-exposure prophylaxis is provided in the cited sources.

Surveillance note

As a notifiable disease in Australia, Murray Valley encephalitis virus infection should be reported promptly upon clinical or laboratory suspicion. Surveillance relies on case-based reporting, mosquito and avian virus screening, and integration with national arbovirus monitoring programs. Due to its rarity and low incidence, detection often depends on active sentinel surveillance in high-risk zones. Interpretation of surveillance data requires consideration of seasonal patterns and vector ecology, though no standardized case definitions or reporting thresholds are specified in the available sources.

Coding Register
ICD-10
ICD-11
Key Statistics
Total cases
70
Peak month
2011-03
Coverage
1 reporting countries · 2000-01-01 → 2026-05-01

Figure 1 | Full historical trajectories across all reporting countries.

Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.

Dataset Archive

Supplementary Data | Multi-country disease dataset

Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.

Rows
317
Data Version
2026-05-09
Coverage
Included metadata
Source links, scope, cadence

Source Register

Official sources and update cadences used to construct the downloadable dataset.

AU
Australia NINDSSmonthlymicrosoft_bi

Australia

Australian national notifiable diseases surveillance dashboard.

Official source
Suggested presentation pattern: cite the data version and coverage window when exporting charts or tables for publication.